Synnöve Lindemalm

Publications
CV
Public outreach and news

Articles

Article: ACTA PAEDIATRICA. 2023;112(12):2551-2559
'Working outside the box'-an interview study regarding manipulation of medicines with registered nurses and pharmacists at a Swedish paediatric hospital
Andersson AC; Lindemalm S; Onatli D; Chowdhury S; Eksborg S; Forberg U
Article: EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2023;32(1):24-29
Frequency of paediatric patients administered extemporaneous preparations at a Swedish university hospital: a registry-based study comparing two study-years, 10 years apart
Andersson AC; Eksborg S; Forberg U; Nydert P; Lindemalm S
Article: ACTA PAEDIATRICA. 2023;112(8):1670-1682
Identifying neonatal adverse events in preterm and term infants using a paediatric trigger tool
Dillner P; Unbeck M; Norman M; Nydert P; Harenstam KP; Lindemalm S; Wackernagel D; Forberg U
Article: JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2023;29(4):818-825
Improved home management of oral pediatric anticancer drugs as a result of an intervention comprising practical training, written instructions and movie clips: A pilot study
El Edelbi RA; Eksborg S; Ekman J; Lindemalm S
Article: JOURNAL OF EVALUATION IN CLINICAL PRACTICE. 2023;29(1):94-100
Parents' experiences of handling oral anticancer drugs at home: 'It all falls on me ...'
El Edelbi RA; Eksborg S; Kreicbergs U; Lovgren M; Wallen K; Ekman J; Lindemalm S
Article: PHARMACEUTICALS. 2022;16(1):8
Manipulated Oral and Rectal Drugs in a Paediatric Swedish University Hospital, a Registry-Based Study Comparing Two Study-Years, Ten Years Apart
Andersson AC; Eksborg S; Foerberg U; Nydert P; Lindemalm S
Article: INTERNATIONAL JOURNAL OF PEDIATRICS AND ADOLESCENT MEDICINE. 2021;8(4):221-228
Estimation of body surface area in neonates, infants, and children using body weight alone.
Akkawi El Edelbi R; Lindemalm S; Nydert P; Eksborg S
Article: ACTA PAEDIATRICA. 2020;109(12):2810-2819
Cross-sectional study identifying high-alert substances in medication error reporting among Swedish paediatric inpatients
Nydert P; Kumlien A; Norman M; Lindemalm S
Article: DRUG, HEALTHCARE AND PATIENT SAFETY. 2020;12:31-40
` Drug Use and Type of Adverse Drug Events-Identified by a Trigger Tool in Different Units in a Swedish Pediatric Hospital
Nydert P; Unbeck M; Harenstam KP; Norman M; Lindemalm S
Article: ONLINE JOURNAL OF PUBLIC HEALTH INFORMATICS. 2017;9(3):e200
Pediatricians' Understanding and Experiences of an Electronic Clinical-Decision-Support-System.
Nydert P; Vég A; Bastholm-Rahmner P; Lindemalm S
Article: STUDIES IN HEALTH TECHNOLOGY AND INFORMATICS. 2017;234:256-261
Evaluation of Electronic Prescribing Decision Support System at a Tertiary Care Pediatric Hospital: The User Acceptance Perspective
Omar A; Ellenius J; Lindemalm S
Article: LAKARTIDNINGEN. 2016;113:DSU3
[Careful medical history taking is worthwhile in child sleep disorders].
Lindemalm S; Winbladh B
Article: ACTA PAEDIATRICA. 2015;104(9):956-961
In situ coating makes it easier for children to swallow and tolerate tablets and capsules
El Edelbi R; Eksborg S; Lindemalm S
Article: BMC HEALTH SERVICES RESEARCH. 2014;14:655
Validation of triggers and development of a pediatric trigger tool to identify adverse events
Unbeck M; Lindemalm S; Nydert P; Ygge B-M; Nylen U; Berglund C; Harenstam KP
Article: ACTA PAEDIATRICA. 2012;101(7):772-778
Paediatric drug use with focus on off-label prescriptions at Swedish hospitals - a nationwide study
Kimland E; Nydert P; Odlind V; Bottiger Y; Lindemalm S
Article: ACTA PAEDIATRICA. 2012;101(5):540-544
Estimation of body surface area in various childhood ages - validation of the Mosteller formula
El Edelbi R; Lindemalm S; Eksborg S
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2011;67(10):1085-1089
Recent drug history in children visiting a pediatric emergency room and documentation in medical records
Kimland E; Bottiger Y; Lindemalm S
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2011;67(7):715-722
Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4β-hydroxycholesterol
Nylen H; Sergel S; Forsberg L; Lindemalm S; Bertilsson L; Wide K; Diczfalusy U
Article: EUROPEAN JOURNAL OF PEDIATRICS. 2011;170(5):583-588
Over-the-counter drug use-estimations within the Swedish paediatric population
Nydert P; Kimland E; Kull I; Lindemalm S
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2011;20(4):393-398
Off-label drug use evaluation in paediatrics-applied to ciprofloxacin when used as treatment of cholangitis
Nydert P; Lindemalm S; Nemeth A
Article: JOURNAL OF HUMAN LACTATION. 2009;25(2):199-205
Transfer of Buprenorphine Into Breast Milk and Calculation of Infant Drug Dose
Lindemalm S; Nydert P; Svensson J-O; Stahle L; Sarman I
Article: EUROPEAN JOURNAL OF PEDIATRICS. 2007;166(6):527-532
Drug related problems and off-label drug treatment in children as seen at a drug information centre
Kimland E; Bergman U; Lindemalm S; Bottiger Y
Article: BMC PHARMACOLOGY. 2005;5:4
Application of population pharmacokinetics to cladribine.
Lindemalm S; Savic RM; Karlsson MO; Juliusson G; Liliemark J; Albertioni F
Article: CANCER LETTERS. 2004;210(2):171-177
Cytotoxicity and pharmacokinetics of cladribine metabolite, 2-chloroadenine in patients with leukemia
Lindemalm S; Liliemark J; Juliusson G; Larsson R; Albertioni F
Article: HAEMATOLOGICA. 2003;88(3):324-332
Comparison of cytotoxicity of 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine (clofarabine) with cladribine in mononuclear cells from patients with acute myeloid and chronic lymphocytic leukemia
Lindemalm S; Liliemark J; Gruber A; Eriksson S; Karlsson MO; Wang YY; Albertioni F
Article: LEUKEMIA RESEARCH. 2001;25(2):133-140
In vitro topo II-DNA complex accumulation and cytotoxicity of etoposide in leukaemic cells from patients with acute myelogenous and chronic lymphocytic leukaemia
Wang YY; Zhou R; Liliemark J; Gruber A; Lindemalm S; Albertioni F; Liliemark E
Article: MEDICAL ONCOLOGY. 1999;16(4):239-244
Distribution of 2-chloro-2′-deoxyadenosine, 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine, Fludarabine and Cytarabine in mice:: a whole-body autoradiography study
Lindemalm SN; Liliemark J; Larsson BS; Albertioni F
Article: CLINICAL CANCER RESEARCH. 1998;4(3):653-658
Pharmacokinetics of cladribine in plasma and its 5′-monophosphate and 5′-triphosphate in leukemic cells of patients with chronic lymphocytic leukemia
Albertioni F; Lindemalm S; Reichelova V; Pettersson B; Eriksson S; Juliusson G; Liliemark J
Article: ANTI-CANCER DRUGS. 1997;8(5):445-453
Stability and analysis of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine and 2-chloroadenine in human blood plasma
Lindemalm S; Albertioni F; Liliemark J
Show more

All other publications

Doctoral thesis: 2001
Pharmacokinetic studies on cladribine
Lindemalm S
Published conference paper: CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 14: STEM CELLS IN LINEAGE SPECIFIC DIFFERENTIATION AND DISEASE. 1998;431:693-697
Relationship between cladribine (CdA) plasma, intracellular CdA-5′-triphosphate (CdATP) concentration, deoxycytidine kinase (dCK), and chemotherapeutic activity in chronic lymphocytic leukemia (CLL)
Albertioni F; Lindemalm S; Eriksson S; Juliusson G; Liliemark J

Employments

Affiliated to Research, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 2022-2025

Degrees and Education

Docent, Karolinska Institutet, 2016
Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2001
University Medical Degree, Karolinska Institutet, 1993

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI